twenty-eight patients with refractory rheumatoid arthritis completed a randomized 24-week double-blind crossover trial comparing oral methotrexate ( 2.5 to 5 mg every 12 hours for three doses weekly ) with placebo .
C0003873
rheumatoid arthritis
C0025677
methotrexate